Hypha Labs, Inc. (FUNI): Capital Expenditures
$33.0K
Year ended 2025-09-30
+23.0%
3-year compound annual growth
-25.2%
5-year compound annual growth
-31.5%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $33.0K | +19.2% | 2026-01-15, From 2024-10-01 |
| 2024-09-30 | $27.7K | n/a | 2026-01-15, From 2023-10-01 |
| No annual figure between 2022-09-30 and 2024-09-30. | |||
| 2022-09-30 | $17.7K | -68.5% | 2023-01-17, From 2021-10-01 |
| 2021-09-30 | $56.2K | -60.2% | 2023-01-17, From 2020-10-01 |
| 2020-09-30 | $141.2K | +212.9% | 2021-12-29, From 2019-10-01 |
| 2019-09-30 | $45.1K | -78.2% | 2021-01-29, From 2018-10-01 |
| 2018-09-30 | $207.4K | +47.2% | 2019-12-31, From 2017-10-01 |
| 2017-09-30 | $140.8K | +923.6% | 2018-12-27, From 2016-10-01 |
| 2016-09-30 | $13.8K | -99.0% | 2017-12-29, From 2015-10-01 |
| 2015-09-30 | $1.44M | n/m | 2017-01-09, From 2014-10-01 |
| 2014-09-30 | $28.3K | n/a | 2016-01-13, From 2013-10-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Hypha Labs, Inc. (FUNI) | 2025-09-30 | $33.0K | +19.2% |
| NeoGenomics Inc (NEO) | 2025-12-31 | $27.01M | -34.2% |
| UL Solutions Inc. (ULS) | 2025-12-31 | $197.00M | -16.9% |
Compare FUNI, NEO, ULS side by side · Screen every company in Services-Testing Laboratories ↗